Having it both ways: how STAT3 deficiency blocks graft-versus-host disease while preserving graft-versus-leukemia activity

Allogeneic hematopoietic cell transplantation can cure patients with high-risk leukemia through graft-versus-leukemia (GVL) effects, the process by which malignant leukemic cells are cleared by donor-derived immune cells from the graft. The problem of harnessing GVL effects while controlling inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandstadter, Joshua D., Outen, Riley, Maillard, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378150/
https://www.ncbi.nlm.nih.gov/pubmed/37526083
http://dx.doi.org/10.1172/JCI172251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378150/
https://www.ncbi.nlm.nih.gov/pubmed/37526083
http://dx.doi.org/10.1172/JCI172251

Ejemplares similares